Skip to main content

Table 1 Prevalence of NHB, hemolytic NHB and treated hemolytic NHB stratified by gestational age (GA) from 2011 to 2016

From: Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States

Estimated GA

Prevalence (95% Confidence Interval)

NHB

Hemolytic NHB

Treated hemolytic NHB

> 37 weeks GA

27.9% (27.7–28.1%)

2.0% (1.9–2.0%)

0.44% (0.41–0.46%)

35–37 weeks GA

38.4% (37.9–38.8%)

2.3% (2.1–2.4%)

0.70% (0.62–0.77%)

< 35 weeks GA

49.4% (48.6–50.1%)

2.8% (2.5–3.0%)

1.09% (0.93–1.25%)

All newborns

30.6% (30.5–30.8%)

2.0% (2.0–2.1%)

0.51% (0.49–0.54%)

  1. NHB neonatal hyperbilirubinemia